vs

Side-by-side financial comparison of BranchOut Food Inc. (BOF) and Bolt Biotherapeutics, Inc. (BOLT). Click either name above to swap in a different company.

BranchOut Food Inc. is the larger business by last-quarter revenue ($4.0M vs $2.5M, roughly 1.6× Bolt Biotherapeutics, Inc.). BranchOut Food Inc. runs the higher net margin — -50.6% vs -265.2%, a 214.6% gap on every dollar of revenue. Over the past eight quarters, BranchOut Food Inc.'s revenue compounded faster (65.4% CAGR vs -31.2%).

Food Lion is an American regional supermarket chain headquartered in Salisbury, North Carolina, that operates over 1,000 supermarkets in 10 states: Delaware, Georgia, Kentucky, Maryland, North Carolina, South Carolina, Pennsylvania, Tennessee, Virginia, and West Virginia. The chain employs over 82,000 people. It was founded in 1957 as Food Town, a single grocery store in Salisbury. It later expanded to many locations across North Carolina. It was independently operated until it was acquired b...

Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company specializing in immune-stimulating antibody conjugate (ISAC) therapies for cancer treatment. Its core pipeline targets hard-to-treat solid tumors, serving global oncology markets and advancing novel immunotherapies that trigger targeted anti-tumor immune responses to improve patient outcomes.

BOF vs BOLT — Head-to-Head

Bigger by revenue
BOF
BOF
1.6× larger
BOF
$4.0M
$2.5M
BOLT
Higher net margin
BOF
BOF
214.6% more per $
BOF
-50.6%
-265.2%
BOLT
Faster 2-yr revenue CAGR
BOF
BOF
Annualised
BOF
65.4%
-31.2%
BOLT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOF
BOF
BOLT
BOLT
Revenue
$4.0M
$2.5M
Net Profit
$-2.0M
$-6.6M
Gross Margin
7.6%
Operating Margin
-47.6%
-283.4%
Net Margin
-50.6%
-265.2%
Revenue YoY
181.9%
Net Profit YoY
-36.5%
58.4%
EPS (diluted)
$-0.15
$-9.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOF
BOF
BOLT
BOLT
Q4 25
$4.0M
$2.5M
Q3 25
$3.2M
$2.2M
Q2 25
$3.3M
$1.8M
Q1 25
$3.2M
$1.2M
Q4 24
$1.4M
$0
Q3 24
$2.2M
$1.1M
Q2 24
$1.4M
$1.3M
Q1 24
$1.5M
$5.3M
Net Profit
BOF
BOF
BOLT
BOLT
Q4 25
$-2.0M
$-6.6M
Q3 25
$-1.6M
$-7.1M
Q2 25
$-1.6M
$-8.6M
Q1 25
$-918.4K
$-11.0M
Q4 24
$-1.5M
$-15.9M
Q3 24
$-1.3M
$-15.2M
Q2 24
$-942.6K
$-21.2M
Q1 24
$-1.1M
$-10.8M
Gross Margin
BOF
BOF
BOLT
BOLT
Q4 25
7.6%
Q3 25
17.7%
Q2 25
18.4%
Q1 25
17.3%
Q4 24
0.9%
Q3 24
15.4%
Q2 24
10.9%
Q1 24
19.3%
Operating Margin
BOF
BOF
BOLT
BOLT
Q4 25
-47.6%
-283.4%
Q3 25
-44.3%
-355.1%
Q2 25
-40.8%
-510.5%
Q1 25
-21.4%
-991.4%
Q4 24
-80.7%
Q3 24
-41.4%
-1441.1%
Q2 24
-60.6%
-1772.3%
Q1 24
-69.9%
-324.1%
Net Margin
BOF
BOF
BOLT
BOLT
Q4 25
-50.6%
-265.2%
Q3 25
-48.8%
-329.4%
Q2 25
-48.6%
-474.6%
Q1 25
-28.8%
-903.4%
Q4 24
-104.5%
Q3 24
-58.3%
-1330.1%
Q2 24
-69.2%
-1662.4%
Q1 24
-71.6%
-205.0%
EPS (diluted)
BOF
BOF
BOLT
BOLT
Q4 25
$-0.15
$-9.38
Q3 25
$-0.14
$-3.72
Q2 25
$-0.17
$-4.46
Q1 25
$-0.11
$-0.29
Q4 24
$-0.16
$-13.73
Q3 24
$-0.19
$-7.93
Q2 24
$-0.22
$-11.12
Q1 24
$-0.26
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOF
BOF
BOLT
BOLT
Cash + ST InvestmentsLiquidity on hand
$27.5M
Total DebtLower is stronger
$4.9M
Stockholders' EquityBook value
$5.6M
$26.5M
Total Assets
$14.5M
$56.7M
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOF
BOF
BOLT
BOLT
Q4 25
$27.5M
Q3 25
$31.9M
Q2 25
$34.8M
Q1 25
$38.8M
Q4 24
$47.3M
Q3 24
$53.8M
Q2 24
$73.7M
Q1 24
$91.3M
Total Debt
BOF
BOF
BOLT
BOLT
Q4 25
$4.9M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BOF
BOF
BOLT
BOLT
Q4 25
$5.6M
$26.5M
Q3 25
$5.1M
$32.1M
Q2 25
$3.5M
$38.8M
Q1 25
$3.9M
$46.8M
Q4 24
$2.3M
$57.2M
Q3 24
$1.5M
$72.0M
Q2 24
$2.0M
$85.9M
Q1 24
$1.7M
$104.2M
Total Assets
BOF
BOF
BOLT
BOLT
Q4 25
$14.5M
$56.7M
Q3 25
$14.7M
$65.1M
Q2 25
$13.2M
$75.5M
Q1 25
$14.1M
$85.9M
Q4 24
$12.9M
$99.6M
Q3 24
$9.6M
$109.3M
Q2 24
$6.7M
$124.2M
Q1 24
$2.7M
$142.9M
Debt / Equity
BOF
BOF
BOLT
BOLT
Q4 25
0.89×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOF
BOF
BOLT
BOLT
Operating Cash FlowLast quarter
$-1.9M
$-7.2M
Free Cash FlowOCF − Capex
$-2.1M
FCF MarginFCF / Revenue
-52.6%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOF
BOF
BOLT
BOLT
Q4 25
$-1.9M
$-7.2M
Q3 25
$-1.1M
$-9.7M
Q2 25
$-2.0M
$-9.6M
Q1 25
$-1.9M
$-13.4M
Q4 24
$-1.6M
$-14.4M
Q3 24
$-1.9M
$-14.0M
Q2 24
$-853.9K
$-16.1M
Q1 24
$-503.6K
$-16.8M
Free Cash Flow
BOF
BOF
BOLT
BOLT
Q4 25
$-2.1M
Q3 25
$-1.2M
Q2 25
$-2.1M
Q1 25
$-2.3M
Q4 24
$-2.3M
Q3 24
$-3.4M
$-14.0M
Q2 24
$-1.4M
Q1 24
$-553.6K
FCF Margin
BOF
BOF
BOLT
BOLT
Q4 25
-52.6%
Q3 25
-37.4%
Q2 25
-64.5%
Q1 25
-72.2%
Q4 24
-163.6%
Q3 24
-157.9%
-1227.6%
Q2 24
-101.3%
Q1 24
-37.7%
Capex Intensity
BOF
BOF
BOLT
BOLT
Q4 25
4.3%
Q3 25
2.6%
Q2 25
3.4%
Q1 25
11.8%
Q4 24
51.1%
Q3 24
70.8%
3.6%
Q2 24
38.6%
0.0%
Q1 24
3.4%
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons